TrialDrug design, development and therapy2021

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD.

Antonio Pardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.